Michael A. Kelly
Kelly founded and is president of Sentry Hill Partners LLC. In 2018, he retired from Amgen Inc. as SVP of global business services and VP and CFO of international commercial operations. He held various leadership positions at Biogen, Tanox and Monsanto Life Sciences.
- 2020 Fourth Quarter
Added to: NeoGenomics Inc. - Fort Myers, FL
NeoGenomics operates a network of cancer-focused testing laboratories. Revenues are $405 million.